CT - 1066
Combination Therapy with Ruxolitinib and Ibrutinib Reduces the Severity of Murine Sclerodermatous Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Niravkumar Brahmbhatt
Poster Presenter: Niravkumar Brahmbhatt
